EMCURE PHARMACEUTICALS L (EMCURE) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1981, Emcure PharmaceuticalsLtd manufactures and markets pharmaceutical products globally[1]

EMCUREUpdated 5 Sept 2026, 2:36

Emcure Pharmaceuticals L

Market Cap

₹36,500Cr.

Current Price

₹1,928

High / Low

₹2,048/1,260

Stock P/E

44.1

ROE22.3%
ROCE23.7%
Book Value₹196
Face Value₹10.0
Dividend Yield0.19%

About

Incorporated in 1981, Emcure PharmaceuticalsLtd manufactures and markets pharmaceutical products globally[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days13517511610912411599107
Inventory Days243200182202214206189197
Days Payable159197168166203220204186
Cash Conversion Cycle22017713014413510184118
Working Capital Days506019170-46153
ROCE %13%20%21%11%10%14%24%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 5 September 2026 at 2:36


Designed & Shipped by Harshit Bansal